C. sativa flower extract fraction, rich in THCA, reduced IL-8 secretion, a marker for IBD inflammation, from HCT116 colonocytes, and CaCO2 cells using GPR55 antagonists blocked the reduction in IL-8, indicating that THCA exerts its effect through this receptor [79]. The gene discussed is CXCL8; the disease is inflammatory bowel disease.